Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment

Published:2020-12 Issue: Volume:208 Page:112831
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Peng Xiaopeng,Sun Zhiqiang,Kuang Peihua,Chen Jianjun^ORCID

Funder

International Science and Technology Cooperation Projects of Guangdong Province

Thousand Youth Talents Program

scientific research project of high-level talents

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference176 articles.

1. Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi;Suraweera;Frontiers in oncology,2018

2. Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents;Mottamal;Molecules,2015

3. HDAC inhibitor LMK-235 promotes the odontoblast differentiation of dental pulp cells;Liu;Mol. Med. Rep.,2018

4. EZH2 promotes tumor progression via regulating VEGF-A/AKT signaling in non-small cell lung cancer;Geng;Canc. Lett.,2015

5. Epigenetic modifications of histone H3 during the transdifferentiation of Thy-1(+) Lin(-) bone marrow cells into hepatocytes;Liao;Mol. Med. Rep.,2015

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of the PRMT6 modulators in cancer treatment: Current progress and emerged opportunity;European Journal of Medicinal Chemistry;2024-12

2. Histone deacetylases: Regulation of vascular homeostasis via endothelial cells and vascular smooth muscle cells and the role in vascular pathogenesis;Genes & Diseases;2024-11

3. Overview of class I HDAC modulators: Inhibitors and degraders;European Journal of Medicinal Chemistry;2024-10

4. Development of a First-in-Class DNMT1/HDAC Inhibitor with Improved Therapeutic Potential and Potentiated Antitumor Immunity;Journal of Medicinal Chemistry;2024-09-12

5. Synthesis, biological evaluation and molecular docking studies of new pyrimidine derivatives as potent dual EGFR/HDAC inhibitors;Journal of Molecular Structure;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3